-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Vr5jJVkiQDQAPlYw6ZzOG5wnu+Z+W7ry6rh+iWIh/R9Pmu7SDyXjxk4yRB59VlqW BBQVqPoTkO20enJ/zyiH5A== 0000950135-07-006050.txt : 20071009 0000950135-07-006050.hdr.sgml : 20071008 20071009105517 ACCESSION NUMBER: 0000950135-07-006050 CONFORMED SUBMISSION TYPE: DEFA14A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20071009 DATE AS OF CHANGE: 20071009 EFFECTIVENESS DATE: 20071009 FILER: COMPANY DATA: COMPANY CONFORMED NAME: POLYMEDICA CORP CENTRAL INDEX KEY: 0000878748 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043033368 STATE OF INCORPORATION: MA FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: DEFA14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-13690 FILM NUMBER: 071161386 BUSINESS ADDRESS: STREET 1: 701 EDGEWATER DRIVE, SUITE 360 CITY: WAKEFIELD STATE: MA ZIP: 01880 BUSINESS PHONE: 781-486-8111 MAIL ADDRESS: STREET 1: 701 EDGEWATER DRIVE, SUITE 360 CITY: WAKEFIELD STATE: MA ZIP: 01880 FORMER COMPANY: FORMER CONFORMED NAME: POLYMEDICA INDUSTRIES INC DATE OF NAME CHANGE: 19930328 DEFA14A 1 b67092pce8vk.htm POLYMEDICA CORPORATION e8vk
Table of Contents

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 5, 2007
POLYMEDICA CORPORATION
(Exact Name of Registrant as Specified in Charter)
         
Massachusetts   0-19842   04-3033368
 
(State or Other Jurisdiction of
Incorporation 		  (Commission
File Number) 		  (IRS Employer
Identification No.)
     
701 Edgewater Road, Suite 360
Wakefield, Massachusetts 		  01880
 
(Address of Principal Executive Offices)   (Zip Code)
Registrant’s telephone number, including area code: (781) 486-8111
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
þ   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 

TABLE OF CONTENTS

Item 8.01. Other Events
SIGNATURE

Table of Contents

Item 8.01. Other Events
In connection with the proposed transaction between PolyMedica Corporation and Medco Health Solutions, Inc., the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, expired at 11:59 p.m. on October 5, 2007.

2

Table of Contents

SIGNATURE
     Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
  POLYMEDICA CORPORATION
 		  
Date: October 9, 2007  By:   /s/ Devin J. Anderson    
    Devin J. Anderson   
    Executive Vice President, General Counsel and
Secretary 		  
 

3

-----END PRIVACY-ENHANCED MESSAGE-----